Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
Weight-inclusive primary care with GLP-1 access. Designed by clinicians frustrated with typical obesity medicine model — focuses on the whole person.
Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.
Noom’s GLP-1 telehealth arm pairing semaglutide/tirzepatide prescribing with behavior-change coaching.
Calibrate’s insurance-billing arm for women whose employer plan covers Wegovy or Zepbound.
Hims & Hers' weight loss division offering compounded GLP-1s plus FDA-approved options. Among the most affordable starting prices.
WeightWatchers-acquired clinical weight loss program. Connects you with board-certified clinicians who can prescribe FDA-approved GLP-1s.
WW’s clinical arm (formerly Sequence) prescribing GLP-1s integrated with the WW behavior program.
Doctor-led GLP-1 weight loss program. Offers compounded semaglutide/tirzepatide and FDA-approved Wegovy/Zepbound for eligible patients.
GLP-1-focused DTC platform offering compounded semaglutide and tirzepatide with monthly delivery.
Whole-person weight loss with GLP-1 medication plus behavioral coaching. One of the larger GLP-1 telehealth programs.
Year-long metabolic health program combining GLP-1 medication with intensive 1:1 coaching. Premium price point, strong outcomes data.
New 2024 entrant focused on women-led GLP-1 prescribing with PCOS comorbidity awareness.
GLP-1 weight loss telehealth with compounded semaglutide and tirzepatide. Direct-to-consumer, async prescribing model.
Direct-to-clinician marketplace where users find providers willing to prescribe compounded semaglutide.
Multi-medication telehealth with strong compounded GLP-1 offering for women. Also offers HRT, peptides, and wellness add-ons.